DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2023 Financial Results
Conference Call and Webcast November 14 at 8:00 AM Eastern Time / 7:00 AM Central Time Updated Amendment to Phase 2/3 ReMEDy2 AIS Protocol Aimed at Enhancing Patient Enrollment and Increasing...
Source: marketscreener.com